The aging glomerulus

Seminars in Nephrology

Volumn 16, Issue 4, 1996, Pages 265-276

  Baylis, Chris ^a   Schmidt, Rebecca ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CREATININE; ENDOTHELIN; GROWTH INHIBITOR; GROWTH PROMOTOR; NITRIC OXIDE; PROSTACYCLIN;

AGING; CHRONIC KIDNEY DISEASE; CREATININE CLEARANCE; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY NERVE; KIDNEY VASCULAR RESISTANCE; LIPID BLOOD LEVEL; MESANGIUM CELL; MICROALBUMINURIA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SEX DIFFERENCE; VASOCONSTRICTION;

AGING; CHRONIC DISEASE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS;

EID: 0029952545     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Baylis C: Renal Biology: The Aging Kidney in Nephrology. London, England, Chapman and Hall, 1995 (in press)
2. Macias-Nunez JF, Cameron JS: Renal function in the elderly, in Cameron S, Davison AM, Grunfeld JP, et al (eds): Oxford Textbook of Clinical Nephrology. Oxford, England, Oxford University, 1992, pp 56-70
3. Chou SY, Lindeman RD: Structural and functional changes in the aging kidney, in Jacobson HR, Striker GE, Klahr S (eds): The Principles and Practice of Nephrology (ed 2). St Louis, MO, Mosby, 1995, pp 510-514
4. Levi M, Rowe JW: Renal function and dysfunction in aging, in Seldin DW, Giebisch G, (eds): The Kidney: Physiology and Pathophysiology. New York, NY, Raven, 1992, pp 3433-3456
5. De Leeuw P: Renal function in the elderly: Results from the European Working Party on High Blood Pressure in the Elderly Trial. Am J Med 90:45-50, 1993 (suppl)
6. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 23:278-285, 1985
7. Feinfeld DA, Guzik H, Carvounis CP, et al: Sequential changes in renal function tests in the old old: Results from the Bronx longitudinal aging study. J Am Geriatr Soc 43:412-414, 1995
8. Dubach UC, Metz I, Schmid P: Serum creatinine values in 2,258 employed subjects of various ages and sex. Klin Wochenschr 45:621-629, 1967
9. Wesson LG Jr. Renal hemodynamics in physiological states, in Physiology of the Human Kidney. New York, NY, Grune and Stratton, 1969, pp 96-108
10. Munger KA, Baylis C: Sex differences in renal hemodynamic in rats. Am J Physiol 254:F223-F231, 1988
11. Baylis C: Age-dependent glomerular damage in the rat: Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest 94:1823-1829, 1994
12. Docherty JR: Cardiovascular responses in ageing: A review. Pharmacol Rev 42:103-125, 1992
13. Hajduczok G, Chapleau MW: Increase in sympathetic activity with age I. Role of impairment of arterial baroreflexes. Am J Physiol 260:H1113-H1120, 1991
14. Baylis C, Engels K, Hymel A, et al: Age-dependent alterations in the metabolic clearance rate (MCR) of angiotensin II (All) in the rat. J Am Soc Nephrol 6:676, 1995 (abstr)
15. Hollenberg NK, Moore TJ: Age and the renal blood supply: Renal vascular responses to Angiotensin converting enzyme inhibition in healthy humans. J Am Geriatr Soc 42:805-808, 1994
16. Baylis C: Renal responses to acute angiotensin II (AII) inhibition and administered AII in the ageing, conscious chronically catheterized rat. Am J Kidney Dis 22:842-850, 1993
17. Heudes D, Michel O, Chevalier J, et al: Effect of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function. Am J Physiol 266:R1038-R1051, 1994
18. Anderson S, Rennke HG, Zatz R: Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats. Am J Physiol 267:F35-F43, 1994
19. Komatsu K, Frohlich ED, Ono H, et al: Glomerular dynamics and morphology of aged spontaneously hypertensive rats. Effects of Angiotensin-converting enzyme inhibition. Hypertension 25:207-213, 1995
20. Vienet R, Grognet JM, Ezan E, et al: Effect of chronic converting-enzyme inhibition on kidney function of senescent hypertensive rats. J Cardiovasc Pharmacol 23:19-25, 1994 (suppl)
21. Kumazaki T, FujiiT, Kobayashi M, et al: Aging- and growth-dependent modulation of endothelin-1 gene expression in human vascular endothelial cells. Exp Cell Res 211:6-11, 1994
22. Dohi Y, Luscher T: Aging differentially affects direct and indirect actions of endothelin-1 in perfused mesenteric arteries of the rat. Br J Pharmacol 100:889-893, 1990
23. Badr KF, Murray JJ, Breyer MD, et al: Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest 83:336-342, 1989
24. Menconi M, Taylor L, Martin B, et al: A review: Prostaglandins, aging, and blood vessels. Geriatr Biosci 35:239-247, 1987
25. Hornych A, Forette F, Bariety J, et al: The influence of age on renal prostaglandin synthesis in man. Prostaglandins Leukot Essent Fatty Acids 43:191-195, 1991
26. Rathaus M, Greenfeld Z, Podjarny E, et al: Sodium loading and renal prostaglandins in old rats. Prostaglandins Leukot Essent Fatty Acids 49:815-819, 1993
27. Johnson AG, Day RO: The problems and pitfalls of NSAID therapy in the elderly (Part 1). Drugs Aging 1:130-143, 1991
28. Schlondorff D: Renal complications of nonsteroidal anti-inflammatory drugs. Kidney Int 44:643-653, 1993
29. Favre L, Glasson P, Valloton MD: Reversible acute renal failure from combined triamterene and indomethacin-A study in health subjects. Ann Intern Med 96:317-320, 1982
30. Gurwitz JH, Avorn J, Ross-Degnan D, et al: Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. JAMA 264:471-475, 1990
31. Buchannan WW: Implications of NSAID therapy in elderly patients. J Rheumatol 17:29-32, 1990
32. Asokan A, Fancourt GJ, Bennett SE: Renal prostaglan-dins, effective renal plasma flow and glomerular filtration rate in healthy elderly subjects. Age Ageing 21:39-42, 1992
33. Haynes WG, Noon JP, Walker BR, et al: Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 11:1375-1380, 1993
34. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-141, 1991
35. Baylis C, Harton P, Engels K: Endothelial derived relaxing factor (EDRF) controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1:875-881, 1990
36. Tominaga M, Fujii K, Abe I, et al: Hypertension and ageing impair acetylcholine-induced vasodilation in rats. J Hypertens 12:259-268, 1994
37. Dohi Y, Thiel MA, Buhler FR, et al: Activation of endothelial L-arginine pathway in resistance arteries. Hypertension 15:170-179, 1990
38. Sonaka I, Futami Y, Maki T: L-Arginine-nitric oxide pathway and chronic nephropathy in aged rats. J Gerontol Biol Sci 49:B157-B161, 1990
39. Reckelhoff JF, Kellum JA, Blanchard EJ, et al: Changes in nitric oxide precursor, L-arginine, and metabolites, nitrate and nitrite, with aging. Life Sci 55:1895-1902, 1994
40. Hollenberg NK, Adams DF, Solomon HS, et al: Senescence and the renal vasculature in normal man. Circ Res 34:309-316, 1974
41. Hill C, Engels K, Baylis C: The old rat kidney has a normal response to vasodilatory agents acting via nitric oxide (NO) production. J Am Soc Nephrol 4:554, 1993 (abstr)
42. Tank JE, Vora JP: Altered renal vascular responses in the aging rat kidney. Am J Physiol 266:F942-F948, 1994
43. Reckelhoff JF, Manning RD Jr., : Role of endotheliumderived nitric oxide in control of renal microvasculature in aging male rats. Am J Physiol 265:R1126-R1131, 1993
44. Hill C, Engeles K, Baylis C: Endothelial derived relaxing factor (EDRF) and the ageing rat kidney. FASEB J 7:771, 1993 (abstr #4452)
45. Ruilope L, Rodicio J, Garcia Robles R, et al: Influence of a low sodium diet on the renal response to amino acid infusions in humans. Kidney Int 31:992-999, 1987
46. Tolins JP, Raij L: Effects of amino acid infusion on renal hemodynamics: Role of endothelium derived relaxing factor. Hypertension 17:1045-1051, 1991
47. Baylis C, Fredericks M, Wilson C, et al: Renal vasodilatory response to IV glycine in the ageing rat kidney. Am J Kidney Dis 15:244-251, 1990
48. Corman B, Chami-Khazraji S, Schaeverbeke J, et al: Effect of feeding on glomerular filtration rate and proteinuria in conscious aging rats. Am J Physiol 255:F250-F256, 1988
49. Fliser D, Zeier M, Nowack R, et al: Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol 3:1371-1377, 1993
50. Jansen TL, Tan AC, Wollersheim H, et al: Age-dependent vasodilation of the skin microcirculation by atrial natriuretic factor. J Cardiovasc Pharmacol 18:622-630, 1991
51. Kawai Y, Ohhashi T: Age-related changes in relaxant response of vascular smooth muscles to atrial natriuretic peptide. J Pharmacol Exp Ther 252:1234-1239, 1990
52. Moritoki H, Yoshikawa T, Hisayama T, et al: Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide. Eur J Pharmacol 210:61-68, 1992
53. Dunn BR, Ichikawa I, Pfeffer JM, et al: Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ Res 59:237-246, 1986
54. DePriest D, Zimmermann C, Baylis C: Renal effects of administered atrial natriuretic peptide in the conscious, aging rat. Life Sciences 46:785-792, 1990
55. Ohashi M, Fujio N, Nawata H, et al: High plasma concentrations of human atrial natriuretic polypeptide in aged men. J Clin Endocrinol Metab 64:81-85, 1987
56. Haller B, Zust H, Shaw S, et al: Effects of posture and ageing on circulating atrial natriuretic peptide levels in man. J Hypertension 5:551-556, 1987
57. Tan AC, Jansen XL, Termond EPS, et al: Kinetics of atrial natriuretic peptide in young and elderly subjects. Eur J Clin Pharmacol 42:449-452, 1992
58. Wallen T, Landahl S, Hedner T, et al: Atrial peptides, ANP (1-98) and ANP (99-126) in health and disease in an elderly population. Eur Heart J 14:1503-1513, 1993
59. Johnson A, Lermioglu F, Garg UC, et al: A novel biological effect of atrial natriuretic hormone: Inhibition of mesangial cell mitogenesis. Biochem Biophys Res Commun 152:893-897, 1988
60. Mene P, Dunn MJ: Prostaglandins and rat glomerular mesangial cell proliferation. Kidney Int 37:1256-1262, 1990
61. Garg UC, Hassis A: Inhibition of rat mesangial cell mitogenesis by nitric oxide generating vasodilators. Am J Physiol 257:60-66, 1989
62. Dubey RK: Vasodilator derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells. J Pharmacol Exp Ther 269:402-408, 1994
63. Ljungman S: Microalbuminuria in essential hypertension. Am J Hypertens 3:956-960, 1990
64. Baylis C, Fredericks M, Leypoldt K, et al: Mechanisms of proteinuria in aging rats. Mech Age Dev 45:111-126, 1988
65. Damsgaard EM, Froland A, Jorgensen OD, et al: Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 300:297-300, 1990
66. Anderson S, Brenner BM: Effects of aging on the renal glomerulus. Am J Med 80:435-442, 1986
67. Goldstein RS, Tarloff JB, Hook JB: Age-related nephropathy in laboratory rats. FASEB J 2:2241-2251, 1988
68. Masoro EJ, Yu BP: Diet and nephropathy. Lab Invest 60:165-167, 1989 (editorial)
69. Remuzzi A, Puntorieri S, Mazzoleni A, et al: Sex related differences in glomerular ultrafiltration and proteinuria in Munich Wistar rats. Kidney Int 34:481-486, 1988
70. Gray JE, Van Zwieten MJ, Hollandes CF: Early light microscopic changes of chronic progressive nephrosis in several strains of aging laboratory rats. J Gerontol 37:142-150, 1982
71. Fujihara CK, Limongi DMZP, DeOliveira HCF, et al: Absence of focal glomerulosclerosis in aging analbuminemic rats. Am J Physiol 262:947-954, 1992
72. Reckelhoff JF, Samsell L, Racusen L, et al: The effect of ageing on glomerular hemodynamics in the Sprague-Dawley rat. Am J Kidney Dis 20:70-75, 1992
73. Fujihara CK, Limongi DMZP, De Oliveira HCF, et al: Absence of focal glomerulosclerosis in aging analbuminemic rats. Am J Physiol 262:947-954, 1992
74. Yoshida Y, Fogo A, Ichikawa I: Glomerular hemodynamic changes vs hypertrophy in experimental glomerular sclerosis. Kidney Int 35:654-660, 1989
75. Daniels BS, Hosteller TH: Adverse effects of growth in the glomerular microcirculation. Am J Physiol 258:1409-1416, 1990
76. Zatz R, Fujihara CK: Glomerular hypertrophy and progressive glomerulopathy: Is there a definite pathogenetic correlation? Kidney Int 45:27-29, 1994 (suppl)
77. Remuzzi A, Puntorieri S, Alfano M, et al: Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 67:572-579, 1992
78. Baylis C, Wilson CB: Sex and the single kidney. Am J Kidney Dis 13:290-298, 1989
79. Lombet JR, Adler SG, Anderson PS, et al: Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med 114:66-74, 1989
80. Gafter U, Ben-Bassat M, Levi J: Caslration inhibits glomerular hypertrophy and proteinuria in uninephrectomized male rais. Eur J Clin Invest 20:360-365, 1990
81. Gretz N, Zeier M, Geberth S, et al: Is gender a determinant for evolution of renal failure? A study of autosomal dominant polycystic kidney disease. Am J Kidney Dis 14:178-183, 1989
82. West KM, Erdreich L, Stober JA: A detailed study of risk factors for retinopathy and nephropathy in diabeles. Diabetes 29:501-508, 1980
83. Silbiger SR, Neugarten J: The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25:515-533, 1995
84. Floege J, Johnson RJ, Couser WG: Mesangial cells in the pathogenesis of progressive glomerular disease in animal models. Clin Invest 70:857-864, 1992
85. Couser WG, Stilmant MM: Mesangial lesions and focal glomerular sclerosis in the aging rat. Lab Invest 33:491-501, 1975
86. O'Donnell MP, Kasiske BL, Raij L, et al: Effect of ageing on glomerular hemodynamics and morphology. Proc IXth Int Cong Nephrol 397, 1984 (abstr)
87. Dodane V, Chevalier J, Bariety J, et al: Longitudinal study of solute excretion and glomerular ultrastructure in an experimental model of aging rats free of kidney disease. Lab Invest 64:377-391, 1991
88. Reckelhoff JF, Baylis C: Glomerular metalloprotease activity is suppressed by androgens in the ageing kidney. J Am Soc Nephrol 3:1835-1838, 1993
89. Sterzel RB, Schulze-Lohoff E, Weber M, et al: Interactions between glomerular mesangial cells, cytokines, and extracellular matrix. J Am Soc Nephrol 2:126-131, 1992 (suppl)
90. Kasiske BL: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667-672, 1988
91. Doi T, Vlassara H, Kirstein M, et al: Receptor specific increased mesangial cell extracellular matrix production is mediated by PDGF. Proc NatI Acad Sei USA 89:2873-2877, 1992
92. Harman D: The aging process. Proc Natl Acad Sei USA 78:7124-7128, 1981
93. Halliwell B: Oxidants and human disease: Some new concepts. FASEB J 1:358-364, 1987
94. Lippman RD: Lipid peroxidation and metabolism in aging: A biological, chemical and medical approach. Rev Biol Res Aging 1:315-342, 1983
95. Nath KA, Fishereder M, Hosteller TH: The role of oxidants in progressive renal injury. Kidney Int 45:111-115, 1994 (suppl)
96. Diamond JR: Reactive oxygen species and progressive glomerular disease. J Lab Clin Med 124:489-95, 1994
97. Shah SV: Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35:1093-1106, 1989
98. Sabbatini M, Sansone G, Uccello F, et al: Functional versus structural changes in the pathophysiology of acute ischemic renal failure in aging rats. Kidney Int 45:1355-1361, 1994
99. Ruiz-Torres P, Gonzalez-Rubio M, Lucio-Cazana J, et al: Reactive oxygen species and platelet activating factor synthesis in age-related glomerular sclerosis. J Lab Clin Med 124:489-495, 1994
100. Falk RJ, Jennette JC: Glomerular disease in the elderly, in Jacobson HR, Striker GE, Klahr S (eds): The Principles and Practice of Nephrology (ed 2). St Louis, MO, Mosby, 1995, pp 518-524
101. Shapiro WB: Renal replacement therapy in the elderly, in Jacobson HR, Striker GE, Klahr S (eds): The Principles and Practice of Nephrology (ed 2). St Louis, MO, Mosby, 1995, pp 533-541
102. Kasiske BL, Ma JZ, Louis TA, et al: .Long-term effects of reduced renal mass in humans. Kidney Int 48:814-819, 1995
103. Ohishi A, Suzuki H, Nakamoto H, et al: Status of patients who underwent uninephrectomy in adulthood more than 20 years ago. Am J Kidney Dis 26:889-897, 1995
104. Rostand SG, Kirk KA, Rutsky EA, et al: Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med 306:1276-1279, 1982
105. Lopes AAS, Port FK, James SA, et al: The excess risk of treated end-stage renal disease in blacks in the United States. J Am Soc Nephrol 3:1961-1971, 1993
106. Excerpts from the United States Renal Data System Annual Data Report. Am J Kidney Dis 26:30-50, 1995 (suppl)